Life Summary
Kwak Dal-won is the CEO of HK inno.N.

He is expanding the health supplement and health & beauty (H&B) businesses while also pushing into new areas such as contract development and manufacturing (CDMO) for biopharmaceuticals.

He was born on May 13, 1960.

He graduated from Kyungbock High School in Seoul and the Department of Business Administration at Sungkyunkwan University. He received a master’s degree in marketing from the Sungkyunkwan University Graduate School of Business.

After joining Samsung Group, he worked at CJ CheilJedang’s pharmaceutical division as Head of Sales for the Yeongnam region, Head of Sales Support, and Head of the Second Business Division.

In 2014, when CJ CheilJedang’s pharmaceutical division was spun off as CJ Healthcare, he was appointed Co-CEO. After CJ Healthcare shifted to a single-CEO system under Kang Seok-hee, he led the Competitiveness Enhancement Task Force.

After CJ Healthcare was acquired by Kolmar Korea and renamed HK inno.N, he served as Head of the Ethical Drugs (ETC) Business and Head of Production before being appointed CEO of HK inno.N in 2022.

#HKinnoN #KwakDalwon #biopharma #CDMO #healthsupplements #H&B #SungkyunkwanUniversity #CJHealthcare #KolmarKorea #KoreanCEOs